Warrant Exercise Period

RNS Number : 1661N
Asimilar Group PLC
30 May 2022
 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.

30 May 2022

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Warrant Exercise Period

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT) , provides an update in relation to 2,000,000 warrants to acquire ordinary shares in the Company at 5p per share ("Warrants") held by Sohail Bhatti, a director of the Company.  Under the terms of the warrant instrument, the Warrants must be exercised on or before 31 May 2022, provided that if the Warrant holder is in possession of relevant price sensitive or inside information (an "Insider") and is thereby precluded from exercising his subscription rights or any part of those rights before 31 May 2022, the exercise period shall be extended until 20 business days following the date on which the Warrant holder ceases to be an Insider. 

 

The Company is planning to publish its interim results in June 2022.  Consequently the Board considers that Sohail Bhatti is currently an Insider and therefore will be in a position to exercise the Warrants within 20 business days of the publication of the Interim Results should he choose to so.

 

-Ends-

Contacts

Asimilar Group plc


John Taylor, Non-Executive Chairman

via Buchanan



Cairn Financial Advisers LLP


Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880



Peterhouse Capital Limited


Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797



Buchanan Communications Limited


Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXUKAURUAUVUUR
UK 100